Oct. 4 at 6:23 PM
$HIMS
1. By definition, someone that needs to have a GLP-1 medication compounded for a legitimate medical reason can't take WeGovy.
2. We went through this is 2023 when Costco partnered with Sesame.
3. The vast majority of weight-loss revenue for Hims comes from selling
$199 compounded semaglutide for those with medical reasons who can't take Wegovy, and the
$79 weight loss kits.
The vast majority of Ro and LifeMD weight loss revenue comes from selling patients
$500 Wegovy and Zepbound and an added
$100 membership, which is who Costco is competing with.
The market doesn't have intimate knowledge of these companies and how they make money, they just punish the most well-known of them.
So congratulations once again. Hims is the the telehealth poster boy.
